Marcus Koch

5.7k total citations · 1 hit paper
117 papers, 4.1k citations indexed

About

Marcus Koch is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Marcus Koch has authored 117 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pathology and Forensic Medicine, 36 papers in Neurology and 24 papers in Rheumatology. Recurrent topics in Marcus Koch's work include Multiple Sclerosis Research Studies (80 papers), Peripheral Neuropathies and Disorders (25 papers) and Rheumatoid Arthritis Research and Therapies (16 papers). Marcus Koch is often cited by papers focused on Multiple Sclerosis Research Studies (80 papers), Peripheral Neuropathies and Disorders (25 papers) and Rheumatoid Arthritis Research and Therapies (16 papers). Marcus Koch collaborates with scholars based in Canada, Netherlands and United States. Marcus Koch's co-authors include Jacques De Keyser, Jop Mostert, Maarten Uyttenboogaart, Luanne M. Metz, Elaine Kingwell, Dorothea Heersema, Helen Tremlett, Peter Rieckmann, V. Wee Yong and Olga Kovalchuk and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Marcus Koch

114 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

2013 386 citations Elaine Kingwell, James Marriott et al. BMC Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcus Koch Canada	36	2.2k	891	668	520	492	117	4.1k
Gabriele C. DeLuca United Kingdom	41	3.0k 1.3×	1.2k 1.3×	1.0k 1.5×	769 1.5×	947 1.9×	126	5.8k
Alessandra Lugaresi Italy	36	1.8k 0.8×	1.3k 1.4×	853 1.3×	398 0.8×	377 0.8×	155	4.2k
Øivind Torkildsen Norway	31	1.9k 0.9×	521 0.6×	714 1.1×	322 0.6×	402 0.8×	126	3.3k
Ilaria Casetta Italy	38	1.1k 0.5×	1.2k 1.4×	483 0.7×	331 0.6×	289 0.6×	149	3.8k
Frederick Munschauer United States	31	3.3k 1.5×	1.0k 1.1×	371 0.6×	577 1.1×	472 1.0×	59	4.4k
Jennifer Graves United States	31	1.8k 0.8×	714 0.8×	970 1.5×	374 0.7×	226 0.5×	119	3.4k
Thibault Moreau France	31	3.0k 1.3×	1.4k 1.5×	848 1.3×	818 1.6×	433 0.9×	98	5.7k
Minhua Yang United States	20	2.3k 1.0×	907 1.0×	821 1.2×	646 1.2×	383 0.8×	39	4.2k
Henning Laursen Denmark	37	1.6k 0.7×	1.2k 1.3×	1.5k 2.2×	383 0.7×	1.0k 2.1×	118	5.5k
Fabrizio Giuliani Canada	29	1.4k 0.6×	667 0.7×	1.1k 1.7×	364 0.7×	1.1k 2.3×	69	4.6k

Countries citing papers authored by Marcus Koch

Since Specialization

Citations

This map shows the geographic impact of Marcus Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Koch more than expected).

Fields of papers citing papers by Marcus Koch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Koch. The network helps show where Marcus Koch may publish in the future.

Co-authorship network of co-authors of Marcus Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Koch. A scholar is included among the top collaborators of Marcus Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Koch. Marcus Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leavitt, Victoria M., Robert J. Fox, Jop Mostert, et al.. (2025). Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study. Multiple Sclerosis Journal. 31(7). 866–876. 1 indexed citations

Leavitt, Victoria M., et al.. (2025). The language and memory test: A brief multidomain digital cognitive measure for multiple sclerosis. Multiple Sclerosis Journal. 31(11). 1348–1357.

Leavitt, Victoria M., Leila Simani, Afshin Borhani‐Haghighi, et al.. (2025). Language dysfunction as a primary feature of cognitive decline in neurological populations. Journal of Neural Transmission. 133(3). 397–407.

Koch, Marcus, Lorraine V. Kalia, Justyna R. Sarna, et al.. (2024). Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease. Neurology. 104(1). e210079–e210079.

Strijbis, Eva, Jop Mostert, Jacynthe Comtois, et al.. (2024). Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis. Neurology. 104(2). e210153–e210153. 2 indexed citations

Janssens, Sophie, Bas Jasperse, Frederik Barkhof, et al.. (2023). Association between age and inflammatory disease activity on magnetic resonance imaging in relapse onset multiple sclerosis during long‐term follow‐up. European Journal of Neurology. 30(8). 2385–2392. 7 indexed citations

Koch, Marcus, Luís Brieva, Jop Mostert, et al.. (2023). Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset. Multiple Sclerosis Journal. 29(14). 1776–1785. 6 indexed citations

Koch, Marcus, et al.. (2023). Biomarkers of disability worsening in inactive primary progressive multiple sclerosis. Journal of Neuroimmunology. 387. 578268–578268. 8 indexed citations

Marrie, Ruth Ann, Maria Pia Sormani, Francesca Bovis, et al.. (2023). Improving the efficiency of clinical trials in multiple sclerosis. Multiple Sclerosis Journal. 29(9). 1136–1148. 10 indexed citations

10.

Strijbis, Eva, Pavle Repovic, Jop Mostert, et al.. (2022). The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials. Multiple Sclerosis Journal. 28(10). 1606–1619. 6 indexed citations

11.

Cámara-Lemarroy, Carlos R., et al.. (2022). Serum neurofilament‐light and glial fibrillary acidic protein levels in hydroxychloroquine‐treated primary progressive multiple sclerosis. European Journal of Neurology. 30(1). 187–194. 11 indexed citations

12.

Koch, Marcus, Jop Mostert, Pavle Repovic, et al.. (2021). MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis. Multiple Sclerosis Journal. 28(4). 561–572. 11 indexed citations

13.

Koch, Marcus, Jop Mostert, Pavle Repovic, et al.. (2021). Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS. Multiple Sclerosis Journal. 28(8). 1286–1298. 3 indexed citations

14.

Koch, Marcus, Jop Mostert, Bernard M.J. Uitdehaag, & Gary Cutter. (2021). A comparison of clinical outcomes in PPMS in the INFORMS original trial data set. Multiple Sclerosis Journal. 27(12). 1864–1874. 12 indexed citations

15.

Koch, Marcus, Jop Mostert, Jamie Greenfield, Weiqiao Liu, & Luanne M. Metz. (2020). Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent. Journal of Neurology. 267(9). 2619–2624. 25 indexed citations

16.

Koch, Marcus, T. Jock Murray, John D. Fisk, et al.. (2014). Hand dexterity and direct disease related cost in multiple sclerosis. Journal of the Neurological Sciences. 341(1-2). 51–54. 17 indexed citations

17.

Kingwell, Elaine, James Marriott, Nathalie Jetté, et al.. (2013). Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurology. 13(1). 128–128. 386 indexed citations breakdown →

18.

Koch, Marcus, Luanne M. Metz, & Olga Kovalchuk. (2012). Epigenetic changes in patients with multiple sclerosis. Nature Reviews Neurology. 9(1). 35–43. 107 indexed citations

19.

Kingwell, Elaine, Marcus Koch, Benjamin S. Leung, et al.. (2010). Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS. Neurology. 74(22). 1822–1826. 75 indexed citations

20.

Ayaz, Derya, Marcus Koch, Mohammed Srahna, et al.. (2008). Axonal Injury and Regeneration in the Adult Brain of Drosophila. Journal of Neuroscience. 28(23). 6010–6021. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact